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Since the cloning of the bcl-2 gene in 1985, considerable progress has been made in elucidating the function of Bcl-2 and related proteins
in controlling apoptosis. Although much of this work initially relied on the ectopic expression of bcl-2 gene family members in cell lines in
vitro, a number of genetically manipulated mice have been generated to better understand the in vivo significance of specific family members
to organ development and homeostasis. Of the many tissues that exhibit apoptosis at some point during fetal or postnatal life, the female
gonads arguably possess one of the highest and most protracted incidences of apoptosis, associated with development and maturation of the
germ line. Moreover, female germ cells (oocytes) are, for as-yet poorly understood reasons, extremely vulnerable to a host of pathological
insults, such as anti-cancer therapies, that ultimately cause premature ovarian failure and infertility due to accelerated oocyte death.
Accordingly, efforts to understand the occurrence and regulation of apoptosis in the ovary are of considerable importance from both
biological and clinical perspectives. This review will highlight what is known of apoptosis in the female gonads, and the role that Bcl-2
family members play in regulating this process.
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The female gonad is a complex, multi-compartmental
structure with diverse, if not unique, biological functions
that include production of fertilization-competent germ cells
(oocytes) and synthesis of a variety of hormones capable of
influencing the function of many other organs and tissues in
the body. Current dogma supports the concept that germ cell
production in most mammalian females is restricted to fetal
or early neonatal life, ceasing during the perinatal period to
yield a reserve of oocytes arrested in meiosis-I and enclosed
by a specialized population of somatic epithelial cells
referred to as granulosa cells [1–4]. This germ cell-somatic
cell unit, termed a follicle, then progresses through a series
of maturational steps involving growth of the oocyte and
proliferation of the granulosa cells, as well as the recruit-
ment of a second somatic cell lineage, termed theca-inter-0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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[4,5]. Under the appropriate hormonal conditions, the fully
matured follicle releases the oocyte into the reproductive
tract for fertilization and subsequent embryonic develop-
ment. In the adult female, this process is continuously
operational throughout reproductive life, terminating when
the supply of oocytes has been exhausted. At this point,
ovarian senescence occurs, which in humans drives the
menopause [6–10]. Importantly, however, only a small
fraction of the pool of oocytes generated during gameto-
genesis survives to be ovulated for fertilization. For exam-
ple, in the human female it has been estimated that nearly
7 106 germ cells are produced in the fetal ovaries by mid-
gestation, but only 1106 or so remain in the ovaries at or
shortly after birth [11,12]. The number of oocytes continues
to decline throughout juvenile and adult life, such that only
a few hundred mostly degenerative oocytes can be found in
the ovaries at the time of the menopausal transition [13].
Given that a woman is capable of ovulating approximately
400 oocytes in her adult lifetime, it is apparent that more
than 99.9% of the potential germ cell population generated
in the human female degenerate rather than survive. Pro-
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loss have also been reported for other species, including the
rat and mouse [6,7,14–16].2. The role of apoptosis in germ cell depletion in the
female
The first reported observation of apoptosis in the ovary,
which is also one of the earliest descriptions of physiolog-
ical cell death in any tissue, was made in 1885 by a series of
studies that documented morphological differences in gran-
ulosa cells of healthy and degenerating follicles of the rabbit
ovary [17]. And while it took almost a century for scientists
to re-initiate evaluations of ovarian cell death in earnest
[18–20], apoptosis has since been implicated in a spectrum
of processes associated with normal and abnormal ovarian
function, including germ cell depletion. Since this topic has
been reviewed in detail very recently [21], the following
section will touch on only a few key points related to when
and why female germ cell death occurs.
As pointed out earlier, large numbers of germ cells are
eliminated from the ovaries during fetal development and
very early neonatal life, and numerous studies have con-
firmed that the loss of germ cells from the fetal and neonatal
ovaries occurs via apoptosis [22–25]. Several hypotheses
have been offered to explain why so much germ cell death is
observed during development of the mammalian female
gonads, including inadequate growth/survival factor support
from neighboring somatic cells as well as quality-control
surveillance during meiotic entry [21]. Recent studies of the
developing mouse ovary have also revealed the presence
and coordinated breakdown of germ-line ‘cysts’ [15], sim-
ilar to that observed during oogenesis in the Drosophila
ovary [26,27]. However, the exact contribution, if any, of
each of these processes to the overall number of female
germ cells lost during development is unknown [21].
For the majority of those germ cells that survive the pre-
and peri-natal waves of apoptosis, now enclosed by somatic
cells as follicles, their fate is not any better as apoptosis
continues to decimate the oocyte pool through a process
referred to as follicular atresia. Atresia can occur at any
stage of follicle maturation in the post-natal ovary; however,
histological studies have revealed that the cell lineage
responsible for triggering degeneration of the follicle
changes depending on the developmental status of the
follicle. In those follicles that serve as the resting pool
(primordial) or are at the earliest stages of maturation
(primary, small preantral), apoptosis of the oocyte is be-
lieved to initiate atresia [5,16]. In contrast, once follicles
reach a critical point in their developmental program that
precedes selection for ovulation of the oocyte (late preantral
through antral stage), apoptosis of the follicular epithelial
(granulosa) cells is probably the underlying cause of follicle
degeneration [19,20,28]. Although the end-result of apopto-
sis being first initiated in the oocyte or the granulosa cells isthe same—elimination of that follicle and germ cell from the
ovary—understanding how each ovarian cell lineage acti-
vates or represses death has become a subject of consider-
able interest.
Finally, in closing this section, it should be stressed that
developmental and quality-control cues are not the only
stimuli capable of causing female germ cell depletion via
apoptosis. Studies from a number of laboratories have
shown that an increasing list of pathological insults, in
the form of either environmental biohazards or clinical
(anti-cancer) therapies, can lead to premature ovarian
failure and infertility by hijacking the intrinsic program
of apoptosis present in oocytes [21]. For example, polycy-
clic aromatic hydrocarbons (PAH), released by the incom-
plete combustion of fossil fuels and through tobacco
smoking, have recently been shown to accelerate oocyte
loss in mouse and human ovaries by activating apoptosis in
oocytes [29,30]. Other studies have demonstrated that
ovarian failure often observed as a consequence of treating
young girls and reproductive-age women for cancer—with
either chemotherapy or radiation—is a consequence of
massive oocyte apoptosis being induced as a side effect
the treatments [31]. Accordingly, new therapies specifically
designed to protect or shield oocytes from the pro-apopto-
tic actions of anti-cancer treatments are being developed
[32,33] and show great promise for eventual clinical appli-
cation [21,34,35].3. Expression of Bcl-2 family members in the female
gonads
As a preface for the following two sections, it should be
kept in mind that Bcl-2 family members comprise only a
part of a much larger story of how apoptosis is activated or
repressed in various cell lineages of the female gonads.
Indeed, numerous studies not cited herein have character-
ized a wide spectrum of extracellular and intracellular cues,
signal transduction pathways and post-mitochondrial execu-
tioners that regulate or mediate apoptosis in ovarian germ
cells and somatic cells. Therefore, the following discussions
should be viewed from the perspective that Bcl-2 family
members, while unquestionably central to the regulation of
cell death in the ovary, still only serve as downstream
effectors of a multitude of other signaling systems set in
motion by such things as survival factor availability, cell-to-
cell contact and overt cellular stresses (e.g., DNA damage).
With that said, early work on the role of Bcl-2 family
members in regulating cell death in the ovary focused on
endogenous gene expression analyses, and the most studied
family member to date is Bax. The first report in this regard
showed in rats that ovarian granulosa cell survival promoted
by gonadotropin hormones is correlated with a reduction in
the level of bax expression in the absence of any change in
bcl-2 or bcl-xL levels [36]. Moreover, in this study [36] and in
subsequent studies of the rat [37–40], human [41], monkey
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mRNA and protein level—has been consistently correlated
with granulosa cell demise and follicular atresia. The gene
encoding Bax is also expressed in female germ cells [44,45],
and studies of the developing mouse ovary have shown that
apoptosis of fetal germ cells is as well correlated with
increased levels of Bax accumulation in the absence of any
change in Bcl-2 levels [46]. Interestingly, microinjection of
recombinant Bax protein into isolated oocytes is, in itself,
fully capable of inducing apoptosis [32], indicating that
elevating cytoplasmic Bax levels is sufficient to drive the
apoptosis program in female germ cells.
Perhaps the most striking example of a relationship
between bax expression and apoptosis in the ovary comes
from studies of how PAH cause oocyte death. As men-
tioned earlier, PAH are released into the environment
during the incomplete combustion of fossil fuels (http://
www.atsdr.cdc.gov/tfacts69.html). Another primary route
of human exposure to PAH is through tobacco smoking
[47]. In addition to being considered general human health
hazards by the Agency for Toxic Substances and Disease
Registry (http://www.atsdr.cdc.gov/tfacts69.html), the ad-
verse effects of PAH on specifically female reproductive
function have been well documented in epidemiological
and animal studies [47–52]. However, the mechanisms by
which PAH damage reproductive tissues and impair fertil-
ity remained, until recently, poorly understood. Although
many chemicals are known to damage the female gonads,
this class of chemicals is particularly interesting, as there
exists an intracellular binding protein for PAH termed the
aryl hydrocarbon receptor (AHR), a transcription factor of
the Per-Arnt-Sim gene family [53–55]. A recent study thus
tested the possibility that the AHR directly regulates the
expression of genes involved in the control of cell death in
oocytes [29]. Computer-based scanning of available gene
sequence databases revealed the presence of consensus
AHR response elements (AHRE) in the promoter of the
pro-apoptotic bax gene. That bax is a transcriptional target
for the AHR was confirmed by testing of the bax gene
promoter in reporter assays with microinjected oocytes
[29]. Utilizing a combination of gene knockout mice and
site-directed mutagenesis, transcriptional activity of the bax
promoter induced by the PAH-activated AHR was shown
to depend on both functional AHR protein in oocytes and
functional AHRE in the bax promoter. In agreement with
these data, treatment of female mice with PAH in vivo
triggers a rapid increase in expression of the endogenous
bax gene in primordial and primary oocytes, followed
shortly by apoptosis [29]. Similar data and conclusions
were derived from studies of mouse fetal ovarian germ cell
death caused by in utero PAH exposure [30], suggesting
that PAH-AHR-driven oocyte loss proceeds via a common
genetic pathway irrespective of the developmental stage of
the ovary. Further, using a human ovarian xenograft model,
it was reported that PAH induce bax expression and
apoptosis in oocytes of human primordial and primaryfollicles in vivo [29], underscoring the evolutionary con-
servation of this pathway.
In addition to Bax, other pro-apoptotic members of the
Bcl-2 family, including both multidomain (e.g., Bcl-xS,
Mtd/Bok, Diva/Boo) and BH3-only (e.g., Bad, Bim) pro-
teins [56–61], are known to be expressed in ovarian germ
cells and/or granulosa cells of various species. As is the case
with Bax, a positive correlation between expression of most
of these proteins and apoptosis in granulosa cells has been
identified, and ectopic overexpression of Mtd/Bok [57] or
Bad [60] can induce granulosa cell death. Of interest, Mtd/
Bok displays a relatively unique specificity for heterodime-
rization with other family members in that this protein
preferentially interacts with the anti-apoptotic Bcl-2-like
protein, Mcl-1 [57,62]. Expression of the mcl-1 gene in
the ovary is evident in granulosa cells of developing
follicles, and gonadotropin-promoted follicle survival is
correlated with an early and transient increase in mcl-1
mRNA levels [63], possibly as a means to offset the pro-
apoptotic actions of Mtd/Bok. These data, coupled with
additional studies of the avian ovary implicating several
other anti-apoptotic Bcl-2 family members as key regulators
of granulosa cell survival [64–66], suggest that the fate of
any given follicle—viz. atretic degeneration or continued
survival until ovulation of the egg—is ultimately determined
by the end-result of a complex interaction between multiple
Bcl-2 family members.4. Bcl-2 family member regulation of oocyte loss:
insights from gene mutant and transgenic mice
Given the large number of publications that have, based
on gene expression analysis, implicated Bax as a key factor
in the initiation of apoptosis in both oocytes and granulosa
cells, it is perhaps not surprising that Bax-deficient mice
have proved so instrumental in solidifying the functional
importance of Bcl-2 family members as pivotal regulators of
cell death in the ovary. In the first report of the generation of
bax mutant mice, ‘‘a marked accumulation of unusual atretic
follicles’’ containing ‘‘numerous atrophic granulosa cells
that presumably failed to undergo apoptosis’’ in ovaries of
Bax-deficient females was noted [67]. As-yet unpublished
work from our laboratory has confirmed that granulosa cells
lacking Bax are indeed defective in their ability activate
apoptosis, collectively supporting the conclusions drawn
from earlier studies of changes in endogenous bax gene
expression in granulosa cells during follicular atresia. Of
even greater interest, subsequent studies reported that Bax-
deficient female mice exhibit a significant reduction in the
incidence of immature (primordial and primary) follicle
atresia due to defective postnatal oocyte apoptosis [16].
This defect in oocyte death leads to a dramatic prolongation
of ovarian life span in aged bax mutant females, essentially
eliminating the mouse equivalent of menopause in these
animals [16].
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germ cell depletion is not restricted to postnatal life as
recent studies reported that bax gene inactivation also
circumvents excessive fetal oocyte death caused by Bcl-x
deficiency in the developing germ line [68]. Interestingly,
however, prenatal oocyte deletion resulting from meiotic
defects is not prevented by bax gene knockout, suggesting
that genetically separable, and possibly stimulus-specific,
pro-apoptotic signaling pathways exist in female germ cells
[69]. In this regard, parallel studies of mice exposed to
various pathological insults have confirmed the fundamental
importance of Bax to some, but not all, paradigms of germ
cell depletion in the female. For example, Bax-deficient
oocytes are resistant to the pro-apoptotic effects of the
chemotherapeutic drug, doxorubicin, both in vitro and in
vivo [31]. Similarly, the massive level of oocyte destruction
observed in female mice exposed to PAH, either in utero or
during postnatal life, is completely absent in animals lacking
functional Bax protein [29,30]. However, germ cell loss
resulting from exposure of female mice to 4-vinylcyclohex-
ene diepoxide (VCD), a hazardous by-product of the man-
ufacture of plastics, rubber, flame-retardants and pesticides,
is only partially overcome by Bax deficiency [70]. Thus,
while Bax certainly plays a critical role in most instances of
germ cell loss from the ovaries, the results from the VCD
study provide additional support to the concept that a Bax-
independent pathway of female germ cell depletion also
exists.
Unfortunately, comparatively little is known of the con-
sequences of inactivating genes encoding other Bcl-2 family
members on female germ cell dynamics. Past studies of
mice lacking Bcl-2 have shown that mutant females possess
a smaller cohort of resting (primordial) follicles in young
adult life [22]—although it is unclear if this phenotype
arises due to excessive germ cell death during fetal devel-
opment, an increased incidence of apoptosis in the germ cell
reserve once endowed in the postnatal gonads, or a combi-
nation of the two. Indeed, targeted (transgenic) expression
of Bcl-2 in mouse oocytes during either fetal development
[71] or postnatal life [72] suppresses apoptosis, indicating
that Bcl-2 is fully capable of promoting germ cell survival in
the female irrespective of the developmental status of the
oocyte or the ovary. In a study of mice with reduced
expression of bcl-x in the germ line, it was reported that
the mutant females were born with a significantly smaller
reserve of oocytes due to excessive germ cell apoptosis
during fetal development [68]. As pointed out earlier,
simultaneous inactivation of the bax gene restores female
germ cell numbers to wild-type levels in neonatal bcl-x
mutant females [68]. Consequently, these types of genetic
evaluations provide in vivo proof that a Bcl-2 family
member rheostat not only exists in female germ cells, but
also functions as a key determinant of oocyte fate during
development. Finally, inactivation of diva/boo, a gene
highly expressed in granulosa cells of the ovary and
correlated with follicular atresia [58,59], causes no obviousabnormalities in the ovary or in fertility [73]. These find-
ings, which indicate that either the absence of Diva/Boo is
compensated for by another Bcl-2 family member or that
Diva/Boo is simply not needed for granulosa cells to
activate apoptosis, underscore the importance of using gene
mutant mice to identify those bcl-2 family members whose
expression is correlated with, rather than required for, the
initiation or suppression of apoptosis in the ovary.5. Conclusions
From the data overviewed above, it is clear that Bcl-2
family members are fundamental components of the much
broader regulatory pathways responsible for controlling
ovarian germ cell and epithelial (granulosa) cell fate. Al-
though Bax has emerged as a, if not the, central figure in this
regard, much more work is needed to determine if other Bcl-2
family members play equally important roles. Somewhat
surprisingly, aside from limited information discussed earlier
regarding what is known of the consequences of bcl-2, bcl-x
or diva/boo gene inactivation on the ovaries or female germ
cell dynamics, little effort has been made to rigorously
examine the relatively large number of bcl-2 gene family
mutants currently available [74] for potential defects in
oocyte or granulosa cell apoptosis. Furthermore, essentially
nothing is known of the expression or function of BH3-only
members of the Bcl-2 family in the gonads, despite mounting
evidence from other cell types and organ systems that these
proteins play crucial roles in ‘sensing’ various types of
cellular stress and thus driving the activation of apoptosis
[75,76]. These types of studies, which represent one of the
main research directions being pursued in our own laboratory,
are clearly needed to provide a much clearer picture of Bcl-2
family member function in the ovaries. In addition, compar-
ative evaluations of the role(s) of bcl-2 gene family orthologs
in controlling germ line death in invertebrate model systems,
such as Caenorhabditis elegans [77], will be of great interest
to follow. Finally, given the central importance of apoptosis in
female germ cell loss under both normal and pathological
situations [21], a better understanding of the molecular
framework responsible for dictating oocyte fate will in all
likelihood open new opportunities for the development of
apoptosis-based therapeutic strategies designed to improve
the reproductive health and well being of women [78].Acknowledgements
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